Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) last traded at $2.11. (NASDAQ:EKSO) performance year to date is -46.98%. The 200 day simple moving average is -42.56%. The 200 SMA is considered a major indicator by market analysts and traders for determining the long-term trend. The price in the market that coincides with the 200 day SMA is recognized as a key support when price moves above the 200 day SMA or resistance when price drops below the same.
Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has been in the buzz for all the right reasons.
The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.
The Exponential Moving Average is similar to a simple moving average but it uses a weighting element that exponentially drops from the recent data point. EMA analysis assesses the short term,5 days and 13 days, intermediate term that is 20 days and long-term 50 days EMA. These EMAs will give bullish indications when moving above trailing EMAs and below the latest price and vice versa. EMA alerts comprise crossovers that is the 5 day EMA crosses below/above the 20 day EMA and EMA convergences, 5 day EMA comparable to 13 day EMA. The long term and short term EMA’s of 1.66 and 2.05 are lower than the current trading price suggesting a bullish pattern in both short term as well as long term. .
The relative strength index is a momentum oscillator that can measure the magnitude of stock price and velocity changes. Momentum is computed as the ratio of plus price changes to negative price changes. The RSI assessment compares the prevailing RSI against oversold (30), overbought (70) and neutral (50) conditions. Alerts will apprise you when stocks retreat from overbought/oversold levels or breakthrough neutral (50). The current RSI is 63.16 suggesting a bullish price action.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is all set to report its earnings on May 09/a. As per Zack’s analyst scores, Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) currently has a mean brokerage rating of . On a scale of 1-5, a rating of 1 or 2 would imply a buy, and a rating of 4 or 5 would indicate a sell recommendation. A rating of 3 would represent a hold on the equity. The consensus target price on (NASDAQ:EKSO) is $ with a high of $ and a low of $.
As such, while we consider Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) represents a enthralling growth story open to several attractive markets, it would be fascinating to see how it works for long-term shareholders.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced a collaboration with four leading rehabilitation facilities to establish Centers of Robotic Excellence to help further advance the use of innovative exoskeleton technology for mobility impaired patients.